Literature DB >> 9006348

Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.

S D Bamforth1, S L Lightman, J Greenwood.   

Abstract

The vascular barriers of the central nervous system form a selective cellular interface between the blood and the neural parenchyma and restrict the transfer of both molecules and hematogenous cells. During immune-mediated diseases, leukocyte infiltration becomes dramatically up-regulated and the permeability of these barriers increases, leading to edema formation. The etiology of this damage remains largely unresolved although inflammatory cytokines have been implicated in the process. The effect of the proinflammatory cytokine interleukin (IL)-1 beta on the integrity of the rat blood-retinal barrier (BRB) was investigated up to 14 days after an intravitreal injection. The permeability of the BRB was evaluated quantitatively using the low molecular weight tracer [14C]mannitol. After IL-1 beta administration, a biphasic opening of the BRB to [14C]mannitol was recorded, peaking at 4 to 8 hours and 24 to 48 hours post-injection (PI). The early disruption coincided with the appearance of both polymorphonuclear and mononuclear leukocytes within the retina. By 12 hours PI, BRB permeability had returned to control values despite a continued increase in the number of infiltrating leukocytes. The second, more pronounced increase in barrier permeability detected at 24 to 48 hours PI corresponded with maximal leukocyte infiltration. Barrier dysfunction had resolved by 72 hours, and by 7 days the leukocyte infiltrate had disappeared. The IL-1 beta-induced increase in permeability could be completely abrogated at 4 and 24 hours PI by treating the animals with the histamine H2-receptor antagonist ranitidine, which also reduced leukocyte infiltration by 47.2%. The ability of histamine to disrupt the BRB was demonstrated by intravitreal and intravascular administration, which caused a rapid and significant increase in BRB permeability. Treatment of the animals with the cyclo-oxygenase inhibitor indomethacin had no effect on IL-1 beta-induced disruption of the BRB at 4 hours PI, but by 24 hours PI a significant reduction in permeability was observed that coincided with a 75.2% reduction in the leukocyte infiltrate. The depletion of circulating leukocytes to < 2% of control levels reduced the retinal leukocyte recruitment induced by IL-1 beta by 73.0% and decreased BRB permeability at both 4 and 24 hours after IL-1 beta injection. These data demonstrate that intravitreal IL-1 beta in the rat induces a biphasic opening of the BRB that appears to be mediated through recruited leukocytes and release of the vasoactive amine histamine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006348      PMCID: PMC1858506     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

Review 1.  Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema.

Authors:  M Wahl; A Unterberg; A Baethmann; L Schilling
Journal:  J Cereb Blood Flow Metab       Date:  1988-10       Impact factor: 6.200

2.  The effect of dexamethasone on vascular permeability of experimental brain tumours.

Authors:  P J Luthert; J Greenwood; P L Lantos; O E Pratt
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 3.  Osmotic opening of blood-brain and blood-ocular barriers.

Authors:  S I Rapoport
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

4.  The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.

Authors:  J Greenwood; R Howes; S Lightman
Journal:  Lab Invest       Date:  1994-01       Impact factor: 5.662

5.  In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.

Authors:  M L Jordan; R A Hoffman; E F Debe; R L Simmons
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

6.  Distribution and localization of histamine in bovine and rabbit eye.

Authors:  J Z Nowak; J Nawrocki; C Maslinski
Journal:  Agents Actions       Date:  1984-04

7.  Intra-arterial histamine increases blood-brain transport in rats.

Authors:  P M Gross; G M Teasdale; D I Graham; W J Angerson; A M Harper
Journal:  Am J Physiol       Date:  1982-08

8.  Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.

Authors:  L Claudio; J A Martiney; C F Brosnan
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

9.  Interleukin-1 beta induces histamine release in the rat hypothalamus in vivo.

Authors:  M Niimi; T Mochizuki; Y Yamamoto; A Yamatodani
Journal:  Neurosci Lett       Date:  1994-11-07       Impact factor: 3.046

10.  Histamine can induce leukocyte rolling in rat mesenteric venules.

Authors:  K Ley
Journal:  Am J Physiol       Date:  1994-09
View more
  16 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

Review 2.  Retinopetal axons in mammals: emphasis on histamine and serotonin.

Authors:  Matthew J Gastinger; Ning Tian; Tamas Horvath; David W Marshak
Journal:  Curr Eye Res       Date:  2006 Jul-Aug       Impact factor: 2.424

Review 3.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 4.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

5.  Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.

Authors:  M Villarroel; M Garcia-Ramírez; L Corraliza; C Hernández; R Simó
Journal:  Diabetologia       Date:  2011-03-03       Impact factor: 10.122

Review 6.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.

Authors:  S A Vinores; N L Derevjanik; H Ozaki; N Okamoto; P A Campochiaro
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

7.  Vitreous inflammatory factors in macular edema with central retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

8.  Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons.

Authors:  Peter J B Anderson; Helena R Watts; Sheila Jen; Stephen M Gentleman; Juliet A Moncaster; D T Walsh; Ling-Sun Jen
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells.

Authors:  Sardarpasha Sheikpranbabu; Kalimuthu Kalishwaralal; Deepak Venkataraman; Soo Hyun Eom; Jongsun Park; Sangiliyandi Gurunathan
Journal:  J Nanobiotechnology       Date:  2009-10-30       Impact factor: 10.435

10.  Histamine immunoreactive axons in the macaque retina.

Authors:  M J Gastinger; J J O'Brien; N B Larsen; D W Marshak
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.